These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33771286)

  • 21. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder.
    Roos CR; Nich C; Mun CJ; Babuscio TA; Mendonca J; Miguel AQC; DeVito EE; Yip SW; Witkiewitz K; Carroll KM; Kiluk BD
    Drug Alcohol Depend; 2019 Dec; 205():107648. PubMed ID: 31677490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder.
    Basterfield C; Hester R; Bowden SC
    Neuropsychology; 2019 Jul; 33(5):739-753. PubMed ID: 31021107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.
    Carroll KM; Kiluk BD; Nich C; DeVito EE; Decker S; LaPaglia D; Duffey D; Babuscio TA; Ball SA
    Drug Alcohol Depend; 2014 Apr; 137():3-19. PubMed ID: 24556275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.
    Glasner-Edwards S; Marinelli-Casey P; Hillhouse M; Ang A; Mooney LJ; Rawson R;
    J Nerv Ment Dis; 2009 Apr; 197(4):225-31. PubMed ID: 19363377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.
    Obermeit LC; Cattie JE; Bolden KA; Marquine MJ; Morgan EE; Franklin DR; Atkinson JH; Grant I; Woods SP;
    Addict Behav; 2013 Dec; 38(12):2874-8. PubMed ID: 24018233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence.
    Cook R; Quinn B; Heinzerling K; Shoptaw S
    Addiction; 2017 Jun; 112(6):1077-1085. PubMed ID: 28107598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A qualitative study of methamphetamine users' perspectives on barriers and facilitators of drug abstinence.
    Herbeck DM; Brecht ML; Christou D; Lovinger K
    J Psychoactive Drugs; 2014; 46(3):215-25. PubMed ID: 25052880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug abstinence and cognitive control in methamphetamine-dependent individuals.
    Salo R; Nordahl TE; Galloway GP; Moore CD; Waters C; Leamon MH
    J Subst Abuse Treat; 2009 Oct; 37(3):292-7. PubMed ID: 19339145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.
    Li L; Lopez JC; Galloway GP; Baggott MJ; Everhart T; Mendelson J
    Ther Drug Monit; 2010 Aug; 32(4):504-7. PubMed ID: 20592647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent Microstructural Deficits of Internal Capsule in One-Year Abstinent Male Methamphetamine Users: a Longitudinal Diffusion Tensor Imaging Study.
    Zhuang W; Tang Y; Zhong N; Jiang H; Du J; Wang J; Zhao M
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):523-30. PubMed ID: 27115910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls.
    Zhong N; Jiang H; Du J; Zhao Y; Sun H; Xu D; Li C; Zhuang W; Li X; Hashimoto K; Zhao M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():31-7. PubMed ID: 27085943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P300 event-related potential in abstinent methamphetamine-dependent patients.
    Haifeng J; Wenxu Z; Hong C; Chuanwei L; Jiang D; Haiming S; Zhikang C; Din X; Jijun W; Min Z
    Physiol Behav; 2015 Oct; 149():142-8. PubMed ID: 26051625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV.
    Sun-Suslow N; Saloner R; Serrano V; Umlauf A; Morgan EE; Ellis RJ; Letendre S; Grant I; Heaton RK
    AIDS Behav; 2020 Nov; 24(11):3071-3082. PubMed ID: 32274672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural, functional and spectroscopic MRI studies of methamphetamine addiction.
    Salo R; Fassbender C
    Curr Top Behav Neurosci; 2012; 11():321-64. PubMed ID: 22094881
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.